HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1389.2515.35 (+1.12 %)
PREV CLOSE ( ) 1373.90
OPEN PRICE ( ) 1386.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 957
TODAY'S LOW / HIGH ( )1340.00 1405.55
52 WK LOW / HIGH ( )1292.9 1928.45
NSE1394.4522.15 (+1.61 %)
PREV CLOSE( ) 1372.30
OPEN PRICE ( ) 1375.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20339
TODAY'S LOW / HIGH( ) 1338.05 1434.00
52 WK LOW / HIGH ( )1292.85 1939.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1987
Management Info
Bhupendra V Gandhi - Chairman Rajiv Gandhi - Managing Director
Registered Office

Address Pushpak’ 1st Floor,Panchvati Circle,Motila Hirabhai Road,
Ahmedabad,
Gujarat-380006

Phone 079 – 26445106

Email mail@hester.in

Website www.hester.in

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE
NEWS
02Feb Hester Biosciences informs about outco
Hester Biosciences has informed that Board of Directors, in their Meetin..
30Jan Hester Biosciences informs about discl
Hester Biosciences has informed that the exchange has received the discl..
30Jan Hester Biosciences informs about discl
Hester Biosciences has informed that the exchange has received the discl..
24Jan Hester Biosciences informs about board
Hester Biosciences has informed that the meeting of the Board of Directo..
08Jan Hester Biosciences informs about certi
Hester Biosciences has informed that the details of securities demateria..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit64.75323.42
Gross Profit 86.13 439.24
Operating Profit 125.48602.09
Net Sales 655.052540
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26946.00 (0.74%)
M.Cap (Rs. in Cr)57258.37
Sanofi India (BSE)
 8118.25 (2.06%)
M.Cap (Rs. in Cr)18696.83
Dr. Reddy's Lab (BSE)
 6155.15 (1.78%)
M.Cap (Rs. in Cr)102679.14
Divi's Lab (BSE)
 3436.75 (2.14%)
M.Cap (Rs. in Cr)91234.91
Glaxosmithkline Phar (BSE)
 1943.10 (3.26%)
M.Cap (Rs. in Cr)32917.29
Shareholding Pattern
PROMOTERS 53.73%
NON-INSTITUTION 45.84%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
Motilal Oswal S&P B...0.06
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.